327 related articles for article (PubMed ID: 24730299)
1. Multifunctional polymeric nanocurcumin for cancer therapy.
Shehzad A; Ul-Islam M; Wahid F; Lee YS
J Nanosci Nanotechnol; 2014 Jan; 14(1):803-14. PubMed ID: 24730299
[TBL] [Abstract][Full Text] [Related]
2. Nanocurcumin: A Double-Edged Sword for Microcancers.
Janjua KA; Shehzad A; Shahzad R; Islam SU; Islam MU
Curr Pharm Des; 2020; 26(45):5783-5792. PubMed ID: 33213321
[TBL] [Abstract][Full Text] [Related]
3. Curcumin nanoformulations: a future nanomedicine for cancer.
Yallapu MM; Jaggi M; Chauhan SC
Drug Discov Today; 2012 Jan; 17(1-2):71-80. PubMed ID: 21959306
[TBL] [Abstract][Full Text] [Related]
4. Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer.
Prajakta D; Ratnesh J; Chandan K; Suresh S; Grace S; Meera V; Vandana P
J Biomed Nanotechnol; 2009 Oct; 5(5):445-55. PubMed ID: 20201417
[TBL] [Abstract][Full Text] [Related]
5. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier.
Nair KL; Thulasidasan AK; Deepa G; Anto RJ; Kumar GS
Int J Pharm; 2012 Apr; 425(1-2):44-52. PubMed ID: 22266528
[TBL] [Abstract][Full Text] [Related]
6. Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats.
Zou P; Helson L; Maitra A; Stern ST; McNeil SE
Mol Pharm; 2013 May; 10(5):1977-87. PubMed ID: 23534919
[TBL] [Abstract][Full Text] [Related]
7. A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma.
Hu B; Sun D; Sun C; Sun YF; Sun HX; Zhu QF; Yang XR; Gao YB; Tang WG; Fan J; Maitra A; Anders RA; Xu Y
Biochem Biophys Res Commun; 2015 Dec; 468(4):525-32. PubMed ID: 26482853
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in colloidal delivery systems for nutraceuticals: A case study - Delivery by Design of curcumin.
Kharat M; McClements DJ
J Colloid Interface Sci; 2019 Dec; 557():506-518. PubMed ID: 31542691
[TBL] [Abstract][Full Text] [Related]
9. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.
Bisht S; Feldmann G; Soni S; Ravi R; Karikar C; Maitra A; Maitra A
J Nanobiotechnology; 2007 Apr; 5():3. PubMed ID: 17439648
[TBL] [Abstract][Full Text] [Related]
10. Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.
Shome S; Talukdar AD; Choudhury MD; Bhattacharya MK; Upadhyaya H
J Pharm Pharmacol; 2016 Dec; 68(12):1481-1500. PubMed ID: 27747859
[TBL] [Abstract][Full Text] [Related]
11. Nanoformulations of Nutraceuticals for Cancer Treatment.
Illahi AF; Muhammad F; Akhtar B
Crit Rev Eukaryot Gene Expr; 2019; 29(5):449-460. PubMed ID: 32422001
[TBL] [Abstract][Full Text] [Related]
12. Improving the anticancer activity of curcumin using nanocurcumin dispersion in water.
Basniwal RK; Khosla R; Jain N
Nutr Cancer; 2014; 66(6):1015-22. PubMed ID: 25068616
[TBL] [Abstract][Full Text] [Related]
13. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles.
Adahoun MA; Al-Akhras MH; Jaafar MS; Bououdina M
Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):98-107. PubMed ID: 26747522
[TBL] [Abstract][Full Text] [Related]
14. Drug-loaded nanoemulsion as positive control is an alternative to DMSO solutions for in vitro evaluation of curcumin delivery to MCF-7 cells.
Schultze E; Coradini K; Dos Santos Chaves P; da Silva LP; Buss J; Guterres SS; Collares T; Beck RCR; Pohlmann AR; Seixas FK
Pharmacol Rep; 2017 Dec; 69(6):1408-1412. PubMed ID: 29154195
[TBL] [Abstract][Full Text] [Related]
15. Robust Microfluidic Technology and New Lipid Composition for Fabrication of Curcumin-Loaded Liposomes: Effect on the Anticancer Activity and Safety of Cisplatin.
Hamano N; Böttger R; Lee SE; Yang Y; Kulkarni JA; Ip S; Cullis PR; Li SD
Mol Pharm; 2019 Sep; 16(9):3957-3967. PubMed ID: 31381352
[TBL] [Abstract][Full Text] [Related]
16. Nano Encapsulated Curcumin: And Its Potential for Biomedical Applications.
Chen Y; Lu Y; Lee RJ; Xiang G
Int J Nanomedicine; 2020; 15():3099-3120. PubMed ID: 32431504
[TBL] [Abstract][Full Text] [Related]
17. Advances in nanotechnology-based delivery systems for curcumin.
Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G
Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093
[TBL] [Abstract][Full Text] [Related]
18. Preparation of novel curcumin-loaded multifunctional nanodroplets for combining ultrasonic development and targeted chemotherapy.
Ji G; Yang J; Chen J
Int J Pharm; 2014 May; 466(1-2):314-20. PubMed ID: 24657138
[TBL] [Abstract][Full Text] [Related]
19. The suitability of liposomes for the delivery of hydrophobic drugs - A case study with curcumin.
Kolter M; Wittmann M; Köll-Weber M; Süss R
Eur J Pharm Biopharm; 2019 Jul; 140():20-28. PubMed ID: 31015019
[TBL] [Abstract][Full Text] [Related]
20. Dual-responsive polymer coated superparamagnetic nanoparticle for targeted drug delivery and hyperthermia treatment.
Patra S; Roy E; Karfa P; Kumar S; Madhuri R; Sharma PK
ACS Appl Mater Interfaces; 2015 May; 7(17):9235-46. PubMed ID: 25893447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
